TheraCea Pharma develops clinical diagnostic tools utilizing radiotracer technology for the rapid and accurate detection of cancer and neurological disorders. Their solutions enable timely therapy matching and efficacy assessments, significantly improving patient prognosis by reducing the wait time for treatment decisions from months to days.
Funding
$256K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current diagnostic methods for cancer and neurological disorders often involve lengthy processes, delaying therapy matching and efficacy assessments, which can negatively impact patient outcomes. The extended wait times, often spanning months, limit the ability to make timely adjustments to treatment plans.
Solution
TheraCea Pharma develops radiotracer-based clinical diagnostic tools designed for the rapid and accurate detection of cancer and neurological disorders. Their technology aims to significantly reduce the time required for therapy matching and efficacy assessments, potentially improving patient prognosis. By providing faster insights into treatment effectiveness, TheraCea's solutions enable clinicians to make more informed and timely decisions regarding patient care. The company's tools also facilitate the acceleration of clinical trials by increasing the probability of matching patients with therapies that target specific aspects of their conditions.
Target Audience
TheraCea's primary customers are oncologists, neurologists, and clinical researchers involved in cancer and neurological disorder treatment and research.
Features
- Radiotracer technology for enhanced detection of cancer and neurological disorders.
- Rapid therapy matching capabilities, reducing wait times from months to days.
- Tools for fast efficacy assessments of immunotherapy treatments.
- Technology developed in partnership with the National Science Foundation and National Institutes of Health.